Zecotek Competitors

Pink Sheets . USA . 
Stock . Zecotek Photonics
Zecotek Photonics competes with VentriPoint Diagnostics, Pharma-Bio Serv, Biotricity, and ImmunoCellular Therapeutics; as well as few others. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Zecotek Photonics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Zecotek Photonics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Zecotek Photonics Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Zecotek Photonics competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Zecotek Photonics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Zecotek Photonics and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Zecotek and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Zecotek Photonics does not affect the price movement of the other competitor.

High positive correlations

OASMY
+ 0.72
PBSV
BTCY
+ 0.7
ANPCY
OASMY
+ 0.7
SRBCF
OASMY
+ 0.66
BTCY
OASMY
+ 0.57
ANPCY
SRBCF
+ 0.56
PBSV
  

High negative correlations

OASMY
- 0.55
IMUC
SRBCF
- 0.55
IMUC
ANPCY
- 0.55
VPTDF
BTCY
- 0.45
VPTDF
IMUC
- 0.44
PBSV
IMUC
- 0.33
ALRTF

Risk-Adjusted Indicators

There is a big difference between Zecotek Pink Sheet performing well and Zecotek Photonics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zecotek Photonics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ALRTF  11.35  0.85  0.05  5.39  12.81 
(16.47)
 35.10 
(22.50)
 101.02 
VPTDF  4.95  0.88  0.15 (0.71) 4.40 
(6.61)
 13.13 
(8.20)
 31.88 
ANPCY  10.88 (0.72) 0.00 (2.32) 0.00 
 0.00 
 34.78 
(26.67)
 145.07 
PBSV  2.78  0.05  0.01  0.08  4.11 
(6.71)
 11.11 
(10.00)
 37.29 
BTCY  6.36 (0.47) 0.00  0.18  0.00 
 0.00 
 12.07 
(12.68)
 48.00 
IMUC  20.34  5.79  0.17  0.97  17.12 
(45.46)
 80.00 
(37.50)
 191.76 
NUMIF  7.43  0.38  0.03  3.22  8.03 
(12.67)
 15.63 
(17.50)
 68.91 
SRBCF  149.27  86.08  0.00 (0.37) 0.00 
 0.00 
 0.00 
 0.00 
 5,000 
EMOR  14.44  1.91  0.10  1.08  14.87 
(20.30)
 38.89 
(28.57)
 82.31 
OASMY  4.48 (0.79) 0.00 (2.46) 0.00 
 0.00 
 0.00 
 0.00 
 150.00 
All Fundamental Data

Zecotek Photonics Competitive Analysis

The better you understand Zecotek Photonics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Zecotek Photonics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Zecotek Photonics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALRTF VPTDF ANPCY PBSV BTCY IMUC NUMIF SRBCF EMOR OASMY
 1.27 
 0.02 
ALR
 22.09 
 0.11 
VentriPoint
 2.62 
 0.07 
Angle
 11.11 
 0.60 
Pharma-Bio
 3.57 
 0.29 
Biotricity
 50.00 
 0.11 
ImmunoCellular
 2.58 
 0.03 
Numinus
 0.00 
 0.01 
Sirona
 9.09 
 0.01 
Healixa
 0.00 
 0.01 
Oasmia
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Out of control
Abnormally volatile
Out of control
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Mild
Good
Weakest
Weakest
Weakest
Good
Weakest
Fair
Mild
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Moderate
Small
Low
Low
Risky
High
Strong
Low
Low
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Hold
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Not Rated
Strong Sell
Current Ratio
N/A
6.74
6.55
9.07
1.54
1.51
16.08
2.6
N/A
6.8
Net Asset
193.22 K
9.54 M
47.31 M
20.65 M
5.64 M
N/A
52.63 M
1.29 M
N/A
594.31 M
Profit Margin
N/A
N/A
N/A
0.0519
-0.37
N/A
N/A
N/A
N/A
N/A
EBITDA
(6.4 M)
(3.82 M)
(15.72 M)
1.23 M
(3.21 M)
(6.07 M)
(42.85 M)
(2.3 M)
N/A
(97.54 M)
Operating Margin
-390.28
-124.5
-16.23
0.0606
0.0728
N/A
-2.63
-4.92
N/A
N/A
Current Valuation
51.54 M
28.27 M
145.22 M
4.87 M
35.83 M
(1.69 M)
20.07 M
24.5 M
N/A
6.58 M
Price To Book
N/A
8.27
4.2
1.15
33.02
0.35
1.31
36.93
N/A
0.68
Retained Earnings
N/A
(20.43 M)
(41.22 M)
20.5 M
(139.44 M)
(74.14 M)
N/A
(12.03 M)
N/A
N/A
Current Asset
N/A
1.07 M
7.23 M
22.27 M
11 K
24.56 M
N/A
1.49 M
N/A
N/A
Beta
0.75
0.28
0.43
0.36
1.33
1.03
2.03
-0.36
N/A
0.0522
Number Of Employees
6
17
128
140
46
3
10
12
3
17
Shares Outstanding
551.97 M
156.51 M
26.06 M
22.95 M
26.57 M
4.19 M
262.75 M
251.73 M
77.99 M
179.35 M
Cash Flow From Operations
(1.77 M)
(3.15 M)
(14.01 M)
592.46 K
(2.38 M)
(2.31 M)
(26.23 M)
(2.16 M)
N/A
(145.56 M)
Annual Yield
N/A
N/A
N/A
0.0581
N/A
N/A
N/A
N/A
N/A
0.12
Total Debt
N/A
125.38 K
5.24 M
520.77 K
26.09 M
2.78 M
213.15 K
468.77 K
N/A
N/A
Return On Equity
N/A
-1.35
-0.56
0.0568
-41.01
-23.12
-0.99
-35.56
N/A
-0.25
Z Score
N/A
N/A
10.2
24.0
N/A
-2.8
N/A
10.5
N/A
N/A
Return On Asset
-8.73
-0.64
-0.3
0.033
-0.11
-4.4
-0.33
-1.35
N/A
-0.0875
Book Value Per Share
-0.048
0.034
1.36
0.72
-1.23
-0.033
0.14
0.004
N/A
N/A
Number Of Shares Shorted
N/A
N/A
N/A
N/A
459.95 K
165.95 K
N/A
N/A
N/A
20.72 K
Current Liabilities
N/A
3.05 M
2.2 M
1.67 M
303 K
2.27 M
N/A
801 K
N/A
N/A
Total Asset
193.22 K
9.54 M
47.31 M
20.65 M
5.64 M
30.08 M
52.63 M
1.29 M
N/A
594.31 M
Debt To Equity
N/A
0.022
0.16
0.032
6.45
0.39
0.12
0.6
N/A
0.011
Target Price
N/A
N/A
N/A
1.77
4.0
5.0
0.5
N/A
N/A
6.0
Short Ratio
N/A
N/A
N/A
N/A
5.5
4.13
N/A
N/A
N/A
0.03
Shares Owned By Institutions
N/A
N/A
N/A
N/A
2.04
N/A
2.88
N/A
N/A
N/A
Market Capitalization
33.06 M
32.09 M
92.38 M
20.88 M
14.17 M
2.21 M
49.17 M
20.74 M
15.6 M
21.21 M
Price To Earning
N/A
68.0
N/A
10.0
-6.7
0.02
N/A
-7.33
N/A
N/A
Price To Sales
3460.33
897.04
144.24
0.9
0.54
N/A
6.38
36.46
N/A
31.16
Net Income
(8.44 M)
(3.88 M)
(15.01 M)
1.01 M
(8.42 M)
(5.15 M)
(44.88 M)
(2.31 M)
N/A
(132.72 M)
Earnings Per Share
N/A
-0.018
-0.82
0.04
-0.09
28.91
-0.098
-0.012
N/A
N/A
Shares Owned By Insiders
69.7
1.75
N/A
64.53
39.36
94.96
4.79
10.43
N/A
N/A
Revenue
7.47 K
N/A
1.01 M
19.4 M
13.79 M
N/A
6.49 M
268.02 K
N/A
26.19 M
Working Capital
N/A
(1.99 M)
5.03 M
20.6 M
(16 M)
22.29 M
N/A
692 K
N/A
N/A
Cash And Equivalents
N/A
7.29 M
20.5 M
14.24 M
2.89 M
933.15 K
41.79 M
1.13 M
N/A
N/A
Cash Per Share
N/A
0.05
0.87
0.62
0.05
0.01
0.17
N/A
N/A
N/A
Gross Profit
4.95 K
(6.27 K)
54 K
4.88 M
11.32 M
N/A
1.78 M
199.25 K
N/A
(15.25 M)
Day Typical Price
0.0157
0.11
0.0673
0.58
0.28
0.097
0.0307
0.0051
0.0102
0.005
Accumulation Distribution
9375.0
110774.0
0.0147
0.1
0.13
545.29
387.62
N/A
0.0476
N/A
Market Facilitation Index
N/A
N/A
0.001
0.06
0.04
0.0
N/A
N/A
5.0E-4
N/A
Daily Balance Of Power
0.2
0.8189
(1.80)
1.0
0.25
(2.82)
(0.50)
0.0
(2.00)
0.0
Period Momentum Indicator
2.0E-4
0.0199
(0)
0.06
0.01
(0.11)
(0.0008)
N/A
(0)
N/A
Rate Of Daily Change
1.01
1.22
0.97
1.11
1.04
0.5
0.97
1.0
0.91
1.0
Day Median Price
0.0155
0.11
0.0675
0.57
0.28
0.0905
0.031
0.0051
0.0103
0.005
Price Action Indicator
6.0E-4
0.0121
(0)
0.06
0.015
(0.04)
(0)
N/A
(0.0008)
N/A
Relative Strength Index
51.0
72.72
34.66
44.11
40.28
54.59
45.22
39.74
48.42
17.24
Coefficient Of Variation
1941.01
814.22
(2,929)
3199.37
(1,177)
559.99
2776.57
831.89
960.86
(2,164)
Mean Deviation
11.35
4.95
10.88
2.78
6.36
20.34
7.43
149.27
14.44
4.48
Jensen Alpha
0.845
0.8842
(0.72)
0.0458
(0.47)
5.79
0.3841
86.08
1.91
(0.79)
Total Risk Alpha
(0.59)
0.2363
(2.46)
(0.31)
(1.43)
3.19
(0.57)
20.95
0.3391
(2.18)
Sortino Ratio
0.0473
0.1507
N/A
0.0106
N/A
0.1674
0.0312
N/A
0.1037
N/A
Downside Variance
281.78
25.09
N/A
87.08
N/A
1332.99
112.41
N/A
357.0
N/A
Standard Deviation
16.78
6.72
20.33
5.4
8.32
34.62
11.15
615.8
19.5
16.39
Kurtosis
2.17
1.49
13.85
4.36
1.49
5.27
3.53
65.95
0.0726
25.08
Potential Upside
35.1
13.13
34.78
11.11
12.07
80.0
15.63
N/A
38.89
N/A
Treynor Ratio
5.39
(0.71)
(2.32)
0.0848
0.1782
0.965
3.22
(0.37)
1.08
(2.46)
Maximum Drawdown
101.02
31.88
145.07
37.29
48.0
191.76
68.91
5000.0
82.31
150.0
Variance
281.64
45.15
413.3
29.17
69.29
1198.23
124.23
379204.47
380.16
268.65
Market Risk Adjusted Performance
5.4
(0.70)
(2.31)
0.0948
0.1882
0.975
3.23
(0.36)
1.09
(2.45)
Risk Adjusted Performance
0.0457
0.095
(0.01)
0.0306
(0.05)
0.1349
0.0346
0.0942
0.0825
(0.02)
Skewness
0.7081
1.01
2.84
0.2722
0.5388
1.86
1.05
8.12
0.4146
2.4
Semi Deviation
12.81
4.4
N/A
4.11
N/A
17.12
8.03
N/A
14.87
N/A
Information Ratio
0.0473
0.1123
(0.04)
0.0182
(0.09)
0.1765
0.0297
0.1201
0.1005
(0.05)
Value At Risk
(22.50)
(8.20)
(26.67)
(10.00)
(12.68)
(37.50)
(17.50)
N/A
(28.57)
N/A
Expected Short fall
(16.47)
(6.61)
N/A
(6.71)
N/A
(45.46)
(12.67)
N/A
(20.30)
N/A
Downside Deviation
16.79
5.01
N/A
9.33
N/A
36.51
10.6
N/A
18.89
N/A
Semi Variance
164.06
19.37
N/A
16.9
N/A
293.07
64.54
N/A
221.06
N/A

Zecotek Photonics Competition Performance Charts

Five steps to successful analysis of Zecotek Photonics Competition

Zecotek Photonics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Zecotek Photonics in relation to its competition. Zecotek Photonics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Zecotek Photonics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Zecotek Photonics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Zecotek Photonics, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Zecotek Photonics position

In addition to having Zecotek Photonics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wireless Thematic Idea Now

Wireless
Wireless Theme
Companies providing wireless technology and communication services. The Wireless theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Zecotek Pink Sheet

Zecotek Photonics financial ratios help investors to determine whether Zecotek Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zecotek with respect to the benefits of owning Zecotek Photonics security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY